Home Precisional detection of lymph node metastasis using tFCM in colorectal cancer
Article Open Access

Precisional detection of lymph node metastasis using tFCM in colorectal cancer

  • Dan Yang , Jingling Tang , Yunhuan Zhen , Jindong Yuan , Pingsheng Hu , Xiaoyun Li , Hang Du , Xiaolan Zhang and Yuan Yang EMAIL logo
Published/Copyright: December 13, 2023

Abstract

The detection of colorectal cancer (CRC) lymph node (LN) metastases significantly influences treatment choices, yet identifying them in samples is time-consuming and error-prone. To enhance efficiency, we have established a LN metastasis detection method utilizing triple-parameter flow cytometry (tFCM) and have conducted a comparative assessment of its accuracy and cost-effectiveness in contrast to conventional pathological examinations. This technique utilized biomarkers cytokeratin 20 (CK20), epithelial cell adhesion molecules (EpCAM), and Pan-CK. tFCM’s sensitivity was validated by analyzing known cell line concentrations (SW480 and SW620) in peripheral blood mononuclear cells (PBMCs), with CK20, EpCAM, and Pan-CK showing significant expression in CRC cell lines but not in PBMCs. A strong linear correlation was observed in the mixed leukocyte environment (R 2 = 0.9988). Subsequently, tFCM and pathological sections were employed to analyze LNs from CRC patients, enabling comparison of detection accuracy. Within the 36 LNs studied, tFCM successfully identified tumor cells with varying metastasis degrees, including micro-metastasis and isolated tumor cell clusters. Notably, relying solely on pathological sections led to a potential 25% misdiagnosis rate for LNs. In contrast, tFCM effectively minimized this risk. In summary, compared to traditional pathological sections, tFCM is a more advantageous method for detecting nodal metastasis in CRC patients, offering a more precise prognosis for these patients.

Graphical abstract

1 Introduction

Colorectal cancer (CRC) stands as the predominant malignancy affecting the digestive system globally, with a staggering 1.9 million new cases and 935,000 fatalities recorded worldwide in 2020 [1]. Notably, lymph node (LN) metastases hold paramount significance in terms of treatment response, survival rates, and unfavorable prognostic indicators among CRC patients. A previous investigation unveiled that 32.9% of individuals with CRC exhibited LN involvement leading to local recurrence [2]. Although conventional pathological sections serve as the established means of detecting LN metastases for nodal staging, their accuracy heavily relies on the expertise of pathologists and subjective assessments made under the microscope. Furthermore, they suffer from an inherent limitation, namely the inability to examine larger LNs [3]. Moreover, micro-metastasis (MIC) and isolated tumor cell clusters (ITCs) constitute unfavorable prognostic factors [4,5] and are considered crucial in nodal staging [6]. Unfortunately, the identification of MIC and ITC often eludes conventional pathological sections, even when employing a single marker, such as immunohistochemistry (IHC) [7]. Given the aforementioned challenges, there arises a need for a more rapid and accurate approach to staging that can provide clinical feedback to guide post-surgical treatments for CRC patients.

In recent years, novel techniques such as quantitative real-time polymerase chain reaction (qRT-PCR) [8,9] and the one-step nucleic acid amplification (OSNA®) assay have emerged for detecting metastases in sentinel nodes (SLNs), surpassing the sensitivity of pathological sections [10]. Nevertheless, both RT-PCR and OSNA® exhibit drawbacks, including their reliance on minimal tissue samples, susceptibility to selection bias, and high costs [11]. In contrast, flow cytometry (FCM) presents a simpler, more comprehensive, and time-saving method for sample processing. Studies led by Ola.Winqvist utilized tumor molecular markers in single-parameter or combined double-parameter FCM to detect tumor cells infiltrating LNs in renal cancer [12] and penile cancer [13]. Despite showing promise in nodal staging, FCM still necessitates refinement for the precise detection of varying degrees of LN metastases [14]. Studies have indicated that the expression of Pan-CK in tumor cells correlates with distant metastasis, lymphatic invasion, and tumor budding [15]. Cytokeratin 20 (CK20), on the other hand, serves as the most prevalent immunohistochemical molecular marker employed for routine cancer staging in clinical pathology laboratories [16]. Epithelial cell adhesion molecules (EpCAM), specifically highly expressed in CRC, exhibit negligible expression in both normal and malignant epithelia. As a diagnostic marker, EpCAM has found utility in detecting mature carcinoma cells in mesenchymal organs like blood, bone marrow, or LNs, and particularly in assessing rare circulating tumor cells in carcinoma patients [17].

LN represents immune organs composed of diverse cell populations, while normal gastrointestinal tissues exhibit varying degrees of tumor marker expression. Consequently, employing multiple markers concurrently becomes imperative to accurately identify tumor cells within LNs and minimize staining background originating from immune cells.

In this study, we sought to combine three tumor markers, CK20, EpCAM, and Pan-CK, through triple-parameter FCM (tFCM), with the aim of evaluating whether tFCM could enhance the precision and efficiency of LN metastasis detection in CRC patients.

2 Materials and methods

2.1 Patients

Twenty-two CRC patients (14 men, 8 women; mean age, 60.95 ± 11.36) enrolled between November 2017 and January 2019 and scheduled for primary surgical treatment were included in this study. The characteristics of the included CRC patients are reflected in Table 1, where “nodes in PAD” represent metastasis/total number of LNs in pathological anatomical diagnosis from LN dissection [18]. Inclusion criteria: patients diagnosed with colon or rectal cancer and requiring surgical resection for treatment.

Table 1

Characteristics of patients with CRC

Case number Age Gender Diagnosis T stage N stage Dissection nodes in PAD Tumor Size (cm)
1 38 Male Rectal cancer T3 N2b 11/24 5 × 5
2 64 Female Colon cancer T4b N2a / 5 × 4
3 65 Female Rectal cancer T3 N2a 4/12 4 × 3
4 53 Female Colon cancer T4b N2b 16/37 10 × 8
5 77 Male Colon cancer T3 N2a 4/12 7 × 6
6 43 Male Colon cancer T3 N0 0/11 4.0 × 3.0
7 52 Male Rectal cancer T3 N0 / 8 × 6
8 51 Female Rectal cancer T3 N0 0/12 4 × 3
9 71 Male Rectal cancer T2 N0 0/9 1.5 × 4
10 74 Female Rectal cancer T2 N0 0/10 8 × 1.4
11 52 Male Rectal cancer T3 N0 0/12 2 × 1.8
12 72 Male Rectal cancer T2 N0 0/10 3 × 3
13 62 Female Rectal cancer T3 N1a 1/13 3 × 2 × 1
14 66 Male Rectal cancer T3 N0 0/17 2 × 3; 4 × 2
15 58 Male Rectal cancer T3 N0 0/10 4 × 3
16 53 Male Colon cancer T3 N2a 4/24 5 × 7
17 53 Male Colon cancer T3 N1b 3/24 6 × 5 × 5
18 76 Male Rectal cancer T4b N2b / 4 × 4
19 75 Male Rectal cancer T3 N1 2/8 5 × 6
20 73 Male Colon cancer T3 N0 0/10 3 × 3 × 1.5
21 46 Female Rectal cancer T3 N2b 8/19 3 × 2.8 × 0.6
22 67 Female Colon cancer T3 N0 0/11 3 × 2 × 0.6

N staging of CRC: N0: There is no regional LN is tumor cell metastasized; N1: 1–3 regional LNs are metastases; N1a: 1 regional LN is metastasis; N1b: 2–3 regional LNs are metastases; N2a: 4–6 regional LNs are metastases; N2b: 7 and more LNs are metastases. Nodes in PAD: metastasis/total number of LNs in pathological anatomical diagnosis from LN dissection.

2.2 Cell line

Two colorectal adenocarcinoma cell lines were used in this study. SW480 and SW620 (ATCC, USA) were cultured in L15 medium (Gibco, USA) at 37°C in a humidified atmosphere of 95% air with 5% CO2. The medium was supplemented with 10% fetal bovine serum (BGS, Gibco, USA) and 1% penicillin/streptomycin (Hyclone, USA). SW480 was established from a primary adenocarcinoma of the colon. SW620 was derived from a LN in the same manner as SW480.

2.3 Negative control samples and peripheral blood mononuclear cells (PBMCs)

Three tumor-cell-free LNs from appendicitis patients after appendectomy were set as negative control samples. PBMCs were obtained from the venous blood of medically examined healthy volunteers without tumors and infectious diseases and were isolated using the Ficoll-Paque gradient method by Ficoll (Solarbio, China).

2.4 LN acquisition

LNs were obtained from the patients after colonic surgery; 1 mL of methylene blue was injected subserosal into four areas around the tumor. A few minutes later, the first blue LN is SLN, and the subsequent colored one is non-SLN. Each LN was cut in half through the largest diameter. Half of the LN was placed in DMEM medium supplemented with 10% BGS immediately, cut into pieces, and digested by enzymatic dissociation to obtain single-cell suspensions that could be analyzed by FCM. The other half was soaked in 10% paraformaldehyde diluted by double-distilled water for 8 h to prepare pathological sections in parallel.

2.5 Identification of CRC cells in mixed cultures

To simulate the environmental condition of metastatic LNs, tumor cells SW480, established from a primary adenocarcinoma of the colon, were added to a PBMCs suspension in a three-fold stepwise dilution series (0.9, 0.3, 0.1, 0.0333, 0.0111, 0.0037, and 0.0012%). PBMCs alone served as a negative control. The corresponding markers were then measured using the FCM assay.

2.6 FCM

Single-cell suspensions were resuspended in zombie yellow live/dead dye diluted 1:500 in phosphate buffer saline to mark dead cells. Fc inhibitor blocked the unwanted staining of FcR on the cells. After blocking, the antibodies were added for EpCAM surface staining [configured PE-cy7 (excitation laser 488 nm, Emission wavelength 767 nm), Biolegend, USA] and incubated for 30 min. The stained cells were fixed and permeabilized with the Cytofix/Cytoperm kit (BD, USA). Antibody for Pan-CK intracellular staining [configured APC (Excitation laser 640 nm, Emission wavelength 660 nm), Abcam, UK] and CK20 [configured FITC (Excitation laser 488 nm, Emission wavelength 520 nm), Abcam, UK] were incubated for 30 min. The cells were acquired by FCM with the help of the Beckman Navios (Beckman coulter, USA) using the software FlowJo (TreeStar, Ashland, OR).

2.7 Pathology

The dehydrated LNs were embedded in paraffin following pathologic routine methods. Every paraffin block was cut into 4-μm sections and adhered to a glass slide. The paraffin sections were deparaffinated in xylene and successively rehydrated in alcohol. All the sections were stained for H&E first. If the metastases in the H&E staining sections were negative, IHC was performed on the unstained consecutive sections with a Pan-CK antibody. 10 mM citrate buffer was used as a heat-mediated antigen retrieval and blocked with 10% goat serum for 30 min at room temperature, followed by incubation with Pan-CK (diluted 1/400, Abcam, UK) at 4°C overnight. Anti-mouse horseradish peroxidase polymer was used as the secondary detection system. The LN H&E and IHC results were photographed. The size of the tumor cell cluster was measured by Adobe Photoshop software.

2.8 Clinical nodal staging

Metastases of H&E-stained and IHC-stained LN slides were reviewed independently according to the 8th edition of the American Joint Committee on Cancer staging manual. Tumor cell clusters with a maximum size greater than 2.0 mm are considered macrometastasis (MAC), larger than 0.2 mm but not larger than 2.0 mm or 10–20 tumor cells in the cluster are MIC, smaller than 0.2 mm or single cells are ITC [19].

2.9 Statistical analysis

Each experiment was performed at least three times. Graphpad prism7 and SPSS were applied for analyzing data. The correlation between detected and added CRC cancer cell line was calculated by linear regression of Prism. The value was presented as X ̅ ± SD.

The data tested by SPSS did not conform to the normal distribution, and the variance was not uniform. Therefore, to compare the percentage of positive cells in each group, the Kruskal Wallis of the non-parametric test was chosen to derive the P value. P < 0.05 was considered a statistical significance. Data were evaluated by SPSS for Kappa, sensitivity, specificity, and likelihood ratio of the tFCM method. The relationship between patients’ clinical factors and tFCM diagnosis was assessed by Fisher’s exact test of SPSS.

  1. Informed consent: Informed consent has been obtained from all individuals included in this study.

  2. Ethical approval: The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance with the tenets of the Helsinki Declaration, and has been approved by the Ethics Committee of the Affiliated Hospital of Guizhou Medical University, (approval No. 2014-40, from 7 March 2014).

3 Result

3.1 Detection of tumor cell markers of CRC

The expression of CK20, Epcam, and Pan-CK in two different CRC cell lines, SW480 and SW620, was investigated by FCM. PBMCs were derived from healthy people’s blood set as background cells. The combination of three tumor markers (CK20-Epcam-Pan-CK) was expressed at >97% in two tumor cell lines, but there were no positive events at all (0%) in PBMCs (Figure 1a and b).

Figure 1 
                  The capacity of tFCM in detecting positive events in CRC cell levels. (a) Two CRC cell lines SW480 and SW620 were stained by tumor marker antibodies CK20, EpCAM, and Pan-CK. PBMCs were used as background staining. FCM detected tumor markers’ positive events in cells. With the remaining Pan-CK and EpCAM common positive events, CK20-positive events were gated, which were CK20-EpCAM-PanCK-positive events shown in different cell lines. (b) Statistics of CK20-EpCAM-PanCK-positive events in CRC cell lines and PBMCs. (c) PBMCs suspension was spiked with the tumor cells SW480 with three-fold stepwise dilution series. R
                     2 showed the correlation between added SW480 and detected CK20-EpCAM-PanCK-positive events to analyze the accuracy and sensitivity of three tumor markers by FCM in a mixed leukocyte environment. A representative experiment with 
                        
                           
                           
                              
                                 
                                    X
                                 
                                 ̅
                              
                           
                           \bar{X}
                        
                      ± SD of 3 replicates is presented.
Figure 1

The capacity of tFCM in detecting positive events in CRC cell levels. (a) Two CRC cell lines SW480 and SW620 were stained by tumor marker antibodies CK20, EpCAM, and Pan-CK. PBMCs were used as background staining. FCM detected tumor markers’ positive events in cells. With the remaining Pan-CK and EpCAM common positive events, CK20-positive events were gated, which were CK20-EpCAM-PanCK-positive events shown in different cell lines. (b) Statistics of CK20-EpCAM-PanCK-positive events in CRC cell lines and PBMCs. (c) PBMCs suspension was spiked with the tumor cells SW480 with three-fold stepwise dilution series. R 2 showed the correlation between added SW480 and detected CK20-EpCAM-PanCK-positive events to analyze the accuracy and sensitivity of three tumor markers by FCM in a mixed leukocyte environment. A representative experiment with X ̅ ± SD of 3 replicates is presented.

3.2 Detection of CRC cells in a mixed leukocyte environment

To simulate the environmental condition of metastatic LNs, PBMCs suspension and the tumor cells SW480 were diluted in the three-fold stepwise dilution series (0.9, 0.3, 0.1, 0.0333, 0.0111, 0.0037, and 0.0012%). The tFCM method showed good stability with the coefficient of variance (CV) ranging from 2.75 to 20.91% when detecting the high concentration of SW480 (0.9–0.1%). As the cell concentration decreased, the CV value gradually increased (data not shown). Furthermore, assuming an LN size of approximately 10 × 5 × 5 mm, an MIC of 2 mm is equal to 1.6% of the total number of cells in the average LN. Thus, an MIC of 0.2 mm is equivalent to 0.032% of the total number of cells [13]. The regression line of CK20-EpCAM-Pan-CK showed high accuracy (Figure 1c) in terms of MIC and ITCs concentrations (0.1–0.0012%) and no unspecific background staining, indicating that the combination of the three tumor makers in FCM is reliable and sensitive for detecting metastatic tumor cells at different concentrations in LNs.

3.3 Gating strategy for tFCM-positive tumor cells

Positive events were gated depending on fluorescence minus one control. The gating strategy of triple molecular marker FCM as a sample is shown in Figure 2b. CK20-EpCAM-Pan-CK-positive events were noted as tFCM-positive tumor cells (Figure 2b).

Figure 2 
                  Identification of SLN from CRC patients and FCM gating strategy of tumor cells in LN. (a) During colorectal surgery, patent blue dye was injected around the primary tumor within about 5 min. The first blue-drained LN was SLN, and the next blue LN was non-SLN. (b) The gating strategy of tumor cells in LN: In the first step, cell debris is gated off by FS-A versus SS-A axis. Single cells are gated in from cells in the second. Live cells are gradually gated depending on viability-FMO control (viability-fluorescence minus One, sample stained with all antibodies except viability zombie yellow). From the live cell gate, double molecular positive cells were gated on a CK20 versus EpCAM plot based on the CK20-FMO control and EpCAM-FMO control gating location, respectively. From this double molecular positive population, the frequency of Pan-CK-positive cells was quantified by Pan-CK-FMO control, and the CK20-EpCAM-Pan-CK triple-positive cells represent the tumor cells among the whole population of cells.
Figure 2

Identification of SLN from CRC patients and FCM gating strategy of tumor cells in LN. (a) During colorectal surgery, patent blue dye was injected around the primary tumor within about 5 min. The first blue-drained LN was SLN, and the next blue LN was non-SLN. (b) The gating strategy of tumor cells in LN: In the first step, cell debris is gated off by FS-A versus SS-A axis. Single cells are gated in from cells in the second. Live cells are gradually gated depending on viability-FMO control (viability-fluorescence minus One, sample stained with all antibodies except viability zombie yellow). From the live cell gate, double molecular positive cells were gated on a CK20 versus EpCAM plot based on the CK20-FMO control and EpCAM-FMO control gating location, respectively. From this double molecular positive population, the frequency of Pan-CK-positive cells was quantified by Pan-CK-FMO control, and the CK20-EpCAM-Pan-CK triple-positive cells represent the tumor cells among the whole population of cells.

3.4 FCM and pathology detection of metastatic cells in SLN

Using tumor tissue as the positive control and appendicitis LN as the negative control, we have conducted a comparative analysis of LN metastasis through H&E staining, IHC (Figure 3a), and tFCM techniques (Figure 3b). The tumor cell cluster in MAC LNs could be observed under the microscope in one H&E-stained section (Figure 3a). As depicted in the illustration, the positive outcomes of H&E and IHC in tumor tissue and LNs with tumor metastasis are recapitulated in tFCM, whereas the negative results of appendicitis LNs and N0 LNs are replicated in tFCM. FCM detected positive events in the four MAC LNs simultaneously (Table 2). After a series of continuous pathological sections, three MIC LNs and three ITC LNs were observed by a microscope in the IHC sections (Table 2). No tumor cells were observed in 17 LNs either by H&E or IHC and nor did FCM detect any positive events in these pathologically negative LNs (Figure 3b, N0 LN). There were nine pathologically negative LNs and FCM detected positive events in the LNs (Table 3). The positive events of the nine pathologically negative LNs did not differ in ITC LNs and MIC LNs (Kruskal Wallis-test, P = 1 and P = 1). The nine pathologically negative LNs tended to be metastatic LNs. Among the 22 patients, the nodal staging was updated to metastasis in 7. Two of the seven patients died 3 years after CRC resection (Table 3). The statistics of LN metastases between triple marker FCM and pathology are given in Table 4. Nine of the 36 LNs were misdiagnosed as negative by pathological sections, meaning that 25% of LNs had a risk of being misdiagnosed by pathological sections. The statistics indicated that FCM could detect tumor cells with varying degrees of metastases to LNs in CRC patients, including MIC and ITC LNs and the metastases that could not be detected by pathology.

Figure 3 
                  Metastasis in LNs detected by pathologic section and FCM. The tumor was used as the positive control. LNs from appendicitis patients were set as negative controls. (a) Sections of LNs stained with H&E combined with IHC were examined by the microscope (×100). (b) The gating strategy applied to FACS data analysis: First, CK20 and EpCAM-positive cells were gated, and from this subpopulation, the frequency of Pan-CK-positive cells was quantified.
Figure 3

Metastasis in LNs detected by pathologic section and FCM. The tumor was used as the positive control. LNs from appendicitis patients were set as negative controls. (a) Sections of LNs stained with H&E combined with IHC were examined by the microscope (×100). (b) The gating strategy applied to FACS data analysis: First, CK20 and EpCAM-positive cells were gated, and from this subpopulation, the frequency of Pan-CK-positive cells was quantified.

Table 2

The comparison between different metastatic degree LNs examined by pathology and FCM

Case number Samples Largest dimension of tumor cell cluster(mm) Number of tumor cells draining in LN The type of metastasis Positive events detected by FCM (%)
1 SLN >2 / MAC 1.3000
2 SLN >2 / MAC 0.7200
3 NonSLN >2 / MAC 0.0850
4 NonSLN >2 / MAC 0.0519
5 SLN1 0.0371 17 MIC 0.0720
6 SLN 0.0170 4 ITC 0.0008
NonSLN 0.1022 56 MIC 0.0242
7 SLN 0.0840 12 MIC 0.0094
8 SLN 0.0223 6 ITC 0.0004
9 SLN 0.0474 8 ITC 0.0005
Table 3

Nodal staging and prognosis in positive detected by 3pFCM but negative by pathology LNs

Case number Samples FCM Pathology FCM nodal staging Pathology nodal staging Prognosis
5 SLN1 + + N1 N1a Recover
SLN2 +
10 NonSLN + N1a N0 Died
15 SLN1 + N1 N0 Recover
NonSLN +
16 SLN + N1a N0 Died
17 SLN + N1 N0 Recover
NonSLN1
NonSLN2
NonSLN3 +
20 NonSLN + N1a N0 Recover
22 NonSLN + N1a N0 Recover

+: Tumor cells detected in LN; −: No tumor cells detected in LN.

Table 4

Statistics between triple marker FCM and pathology

Pathology Total
Positive Negative
FCM Positive 10 9 19
Negative 0 17 17
Total 10 26 36

Pathology was designated as the criterion for detecting LN metastases in statistics. SPSS statistical analysis showed moderate agreement between FCM and pathological sections (Kappa = 0.512). The sensitivity and specificity of FCM were 100 and 65.38%, respectively. The positive and negative likelihood ratios of FCM were 2.889 and 0. From the earlier analysis, it could be concluded that there was no risk of missed detection and no false negatives for tFCM (Figure 4).

Figure 4 
                  Summary of LN triple marker FCM results. The frequency of FCM-positive cells in MAC LN, MIC, and ITC LN, and results of differences in LNs between FCM and pathologic section. These samples were analyzed by SPSS software. Kruskal Wallis-test, *P < 0.05.
Figure 4

Summary of LN triple marker FCM results. The frequency of FCM-positive cells in MAC LN, MIC, and ITC LN, and results of differences in LNs between FCM and pathologic section. These samples were analyzed by SPSS software. Kruskal Wallis-test, *P < 0.05.

3.5 Correlation analysis of LN metastases detected by FCM with clinicopathology

The distribution of the clinicopathological factors between patients with pathologically detected tumor cell-metastatic nodes and those without tumor cell nodes was analyzed to define the correlations with LN metastases. The results revealed that LN metastases detected by FCM were significantly associated with cancer type (Fisher’s exact test, P = 0.022). Colon cancer patients were more likely to have metastases in their LNs than rectal cancer patients. Colon cancer is more likely to present with lymph vascular invasion than rectal cancer. These findings could not be observed by pathological examination (Fisher’s exact test, P = 0.662). In addition, the tumor size of node-positive patients was larger than that of node-negative patients, no matter whether examined by FCM or pathology. LN metastases were more prominent in large-sized tumors.

4 Discussion

In this study, we employed a combination of the tumor molecular markers CK20, Pan-CK, and EpCAM to detect metastatic tumor cells in LNs from (CRC) patients. Our findings demonstrated that the utilization of tFCM allowed for accurate identification of different levels of tumor cells in LNs, including MIC and ITC. Consequently, FCM holds the potential to facilitate rapid nodal staging by assisting surgeons.

It typically takes several days for their identification through the examination of MAC-LN sections under a microscope. Furthermore, if MIC and ITC cannot be observed or diagnosed via H&E staining, additional IHC testing is required, which can extend the diagnosis time to at least a week. In contrast, the primary advantage of FCM lies in its reagent cost parity with traditional pathological analysis while significantly economizing time. A single staff member can complete the entire LN FCM assessment within 4 h, whereas pathological examinations necessitate at least 2–4 days and can only detect metastases in fewer than 1/50 LNs. This method significantly reduces the time required for diagnosis and enhances the accuracy of detection, particularly in cases of MICs occurring within the tumor. Furthermore, with further optimization, it can offer valuable assistance to surgeons during procedures.

Previous studies have indicated that patients with cytokeratin-positive cells in LNs, detected by IHC, exhibit a poor prognosis [20]. Cytokeratins (CK) are intracellular proteins that can serve as applicable markers for metastasis detection using FCM. However, since cells must undergo fixation and embedding before FCM analysis, the number of false positive events may increase, as demonstrated by positive events in PBMCs when using CK20 alone. Moreover, the accuracy and sensitivity of using two cytokeratins in combination with the cell surface membrane protein EpCAM were higher than those achieved by utilizing either cytokeratin alone or both cytokeratins simultaneously. Previous research has focused on using one or two tumor markers to develop FCM, but the accuracy of FCM in detecting MIC or ITC remains uncertain [21]. Therefore, in our study, the background fluorescence of the node group was deduced using an isotype control group. It is worth noting that isotype control is typically used as gating in FCM to define true positive and negative events, rather than to calculate positive events, and no isotype can perfectly match the specific antibody used [22,23]. Considering an LN size of approximately 6 × 5 × 4 mm, half of it can yield around 50 sections of 4 μm thickness. However, in routine pathology, only two–five sections are typically examined, resulting in a significant proportion (90%) of the LN going unexamined and thereby posing a high risk of false negatives. A MIC measuring 0.2 mm accounts for merely 0.16% of the total LN cell count, while ITC corresponds to a mere 0.032% of the total LN cell count. In our spiking experiment utilizing the three tumor markers with FCM, we were able to detect 0.00123% of SW480 cells from PBMCs, indicating that the method is stable and sensitive enough for ITC detection. Furthermore, no positive events for CK20-EpCAM-PanCK were detected in PBMCs, LNs without tumor cells, or several pathologically negative nodes. To a certain extent, this substantiates the potential to minimize false positive occurrences when employing the tripartite tumor marker approach. Prior research has indicated that over 95% of CRC cases are classified as adenocarcinomas [24]. Rare histological types encompass six varieties, including squamous cell carcinoma, neuroendocrine tumor, soft tissue sarcoma, gastrointestinal stromal tumor, non-Hodgkin lymphoma, and melanoma. In this study, the FCM antibodies primarily target epithelial tissue origins, which may lead to potential oversight of other rare CRC histological types. Caution must be exercised in their application. Within our study, one case of neuroendocrine carcinoma exhibited negative results in both pathological and flow cytometric examinations of three LNs. Consequently, the possibility of LN metastasis in this patient cannot be entirely ruled out. On another note, multi-parameter FCM presently has the capability to simultaneously assess more than ten antibodies. Hence, there is promise for further optimization of flow cytometric testing protocols. This optimization aims not only to detect tumor metastases but also to scrutinize the immunophenotype of immune cells within LNs, thereby offering additional insights into the prognostic characteristics of CRC [25]. The Meta-Analysis led by Mao et al. has delineated several pivotal risk factors defining LN metastasis in patients afflicted with thyroid carcinoma. These encompass age (<45 years), gender (male), multifocality, tumor dimensions (>1 cm), tumor location (upper one-third), capsular infiltration, and thyroid extracapsular extension [26]. Tsuchihashi and colleagues have established a model for forecasting the risk factors associated with LN metastasis in submucosal CRC (SM CRC). They partition patients based on the presence or absence of LN metastasis in SM CRC into three risk factors: lymphatic vessel invasion, budding grade, and depth of submucosal infiltration [27]. The foundation of such investigations into prognostic factors for LN metastasis hinges on the precise identification of LN metastasis in each case. Herein, tFCM offers a method that combines various immune markers not only for detecting metastasis but also for assessing the invasive potential of draining tumor cells in successive LNs, offering distinct advantages over traditional pathological examinations. Additionally, our future focus will be on optimizing the FCM procedure to reduce the time required and to explore the functional mechanisms underlying metastatic tumor cells in LNs.

5 Conclusion

tFCM represents a rapid, accurate, and automated objective approach for detecting LN metastases in CRC patients. It holds promise for nodal staging and presents a potential alternative to subjective microscopic pathological sections in the diagnostic process for LN involvement.


# These authors contributed equally to this work and share first authorship.


  1. Funding information: This research was supported by the National Natural Science Foundation of China (82260584); Department of Science & Technology of Guizhou Province (Grant No. [2022]-193 and ZK[2023]-359, [2023]-373), Bureau of Science and Technology of Guiyang Municipality (Grant No. [2022] 5-17), Health Commission of Guizhou Province (gzwkj2023-576, gzwkj2023-041, gzwkj2023-450).

  2. Author contributions: D.Y. contributed to the methodology and wrote the original draft. J.T. performed data analysis and also wrote the original draft. Y.Z., J.Y., X.L., and X.Z. collected clinical samples. P.H. conceptualized the project and reviewed the manuscript. H.D. conducted statistical analysis. Y.Y. oversaw project administration and secured funding. All authors have reviewed and approved the published manuscript.

  3. Conflict of interest: Authors state no conflict of interest.

  4. Data availability statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1] Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.10.3322/caac.21660Search in Google Scholar PubMed

[2] Dumont F, Munoz MA, De Franco V, Wernert R, Verriele V, Heyman MF, et al. Significance of lymph node involvement in local recurrence of colorectal cancer. J Surg Oncol. 2019;120:722–8.10.1002/jso.25631Search in Google Scholar PubMed

[3] Balaya V, Guani B, Benoit L, Magaud L, Bonsang-Kitzis H, Ngô C, et al. Diagnostic value of frozen section examination of sentinel lymph nodes in early-stage cervical cancer at the time of ultrastaging. Gynecol Oncol. 2020;158:576–83.10.1016/j.ygyno.2020.05.043Search in Google Scholar PubMed

[4] Guani B, Mahiou K, Crestani A, Cibula D, Buda A, Gaillard T, et al. Clinical impact of low-volume lymph node metastases in early-stage cervical cancer: A comprehensive meta-analysis. Gynecol Oncol. 2022;164:446–54.10.1016/j.ygyno.2021.12.015Search in Google Scholar PubMed

[5] Gómez-Hidalgo NR, Ramirez PT, Ngo B, Pérez-Hoyos S, Coreas N, Sanchez-Iglesias JL, et al. Oncologic impact of micrometastases or isolated tumor cells in sentinel lymph nodes of patients with endometrial cancer: a meta-analysis. Clin Transl Oncol. 2020;22:1272–9. Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.10.1007/s12094-019-02249-xSearch in Google Scholar PubMed PubMed Central

[6] Guani B, Balaya V, Magaud L, Lecuru F, Mathevet P. The clinical impact of low-volume lymph nodal metastases in early-stage cervical cancer: The Senticol 1 and Senticol 2 trials. Cancers (Basel). 2020;12:1061.10.3390/cancers12051061Search in Google Scholar PubMed PubMed Central

[7] Wang YC, Wu RC, Jung SM, Hao L, Yang LY, Chao AS, et al. Detection and prognostic significance of isolated tumor cells and micrometastases in pelvic lymph nodes of patients with early ovarian clear cell carcinoma. J Formos Med Assoc. 2021;120:1869–75.10.1016/j.jfma.2021.03.028Search in Google Scholar PubMed

[8] Togami S, Kawamura T, Fukuda M, Yanazume S, Kamio M, Kobayashi H. Quantitative RT-PCR assay for detecting lymph node metastasis in endometrial cancer: A preliminary study. Oncology. 2019;96:179–82.10.1159/000493485Search in Google Scholar PubMed

[9] Shang J, Zhao M, Deng H, Liu C, Cai L, Liu Y. A clinical diagnostic test on the detection of sentinel lymph node metastasis in breast neoplasms using a 1-step RT-PCR. Gland Surg. 2022;11:1628–38.10.21037/gs-22-485Search in Google Scholar PubMed PubMed Central

[10] Crafa F, Vanella S, Catalano OA, Pomykala KL, Baiamonte M. Role of one-step nucleic acid amplification in colorectal cancer lymph node metastases detection. World J Gastroenterol. 2022;28:4019–43.10.3748/wjg.v28.i30.4019Search in Google Scholar PubMed PubMed Central

[11] Engels S, Brautmeier L, Reinhardt L, Wasylow C, Hasselmann F, Henke RP, et al. Evaluation of fast molecular detection of lymph node metastases in prostate cancer patients using One-Step Nucleic Acid Amplification (OSNA). Cancers (Basel). 2021;13:1117.10.3390/cancers13051117Search in Google Scholar PubMed PubMed Central

[12] Hartana CA, Kinn J, Rosenblatt R, Anania S, Alamdari F, Glise H, et al. Detection of micrometastases by flow cytometry in sentinel lymph nodes from patients with renal tumours. Br J Cancer. 2016;115:957–66.10.1038/bjc.2016.279Search in Google Scholar PubMed PubMed Central

[13] Zhang L, Hu J, Ali Zirakzadeh A, Rosvall J, Hedlund M, Hu PS, et al. Detection of micro-metastases by flow cytometry in lymph nodes from patients with penile cancer. BMC Urol. 2018;18:86.10.1186/s12894-018-0399-3Search in Google Scholar PubMed PubMed Central

[14] Bahnassy AA, Salem SE, Mohanad M, Abulezz NZ, Abdellateif MS, Hussein M, et al. Prognostic significance of circulating tumor cells (CTCs) in Egyptian non-metastatic colorectal cancer patients: A comparative study for four different techniques of detection (Flowcytometry, CellSearch, Quantitative Real-time PCR and Cytomorphology). Exp Mol Pathol. 2019;106:90–101.10.1016/j.yexmp.2018.12.006Search in Google Scholar PubMed

[15] Meyer SN, Galvan JA, Zahnd S, Sokol L, Dawson H, Lugli A, et al. Co-expression of cytokeratin and vimentin in colorectal cancer highlights a subset of tumor buds and an atypical cancer-associated stroma. Hum Pathol. 2019;87:18–27.10.1016/j.humpath.2019.02.002Search in Google Scholar PubMed

[16] Sanguedolce F, Russo D, Calo B, Cindolo L, Carrieri G, Cormio L. Diagnostic and prognostic roles of CK20 in the pathology of urothelial lesions. A systematic review. Pathol Res Pract. 2019;215:152413.10.1016/j.prp.2019.04.005Search in Google Scholar PubMed

[17] Keller L, Werner S, Pantel K. Biology and clinical relevance of EpCAM. Cell Stress. 2019;3:165–80.10.15698/cst2019.06.188Search in Google Scholar PubMed PubMed Central

[18] Milburn JJ, Richard G, Elliot A, Benson IAB, James B, Chang GJ, et al. Colon and rectum. In: Mahul A, Stephen E, Frederick G, David B, Robert B, Kay WM, et al. editors. AJCC Cancer Staging Manual. 8th edn. Berlin: Springer International Publishing; 2016. p. 251–74.Search in Google Scholar

[19] Gabriel NH, James LC, Cari JD, Stephen BE, Elizabeth AM, Hope SR. Breast. In: AJCC Cancer Staging Manual. 8th edn. Berlin: Springer International Publishing; 2016. p. 605–8.Search in Google Scholar

[20] Menz A, Bauer R, Kluth M, Marie von Bargen C, Gorbokon N, Viehweger F, et al. Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors. Hum Pathol. 2021;115:19–36.10.1016/j.humpath.2021.05.012Search in Google Scholar PubMed

[21] Hayry V, Kagedal A, Hjalmarsson E, Neves da Silva PF, Drakskog C, Margolin G, et al. Rapid nodal staging of head and neck cancer surgical specimens with flow cytometric analysis. Br J Cancer. 2018;118:421–7.10.1038/bjc.2017.408Search in Google Scholar PubMed PubMed Central

[22] Andersen MN, Al-Karradi SN, Kragstrup TW, Hokland M. Elimination of erroneous results in flow cytometry caused by antibody binding to Fc receptors on human monocytes and macrophages. Cytom A. 2016;89:1001–9.10.1002/cyto.a.22995Search in Google Scholar PubMed

[23] Spurgeon BEJ, Naseem KM. Platelet flow cytometry: Instrument setup, controls, and panel performance. Cytom Part B Clin Cytom. 2020;98:19–27.10.1002/cyto.b.21774Search in Google Scholar PubMed

[24] Hrudka J, Fiserova H, Jelinkova K, Matej R, Waldauf P. Cytokeratin 7 expression as a predictor of an unfavorable prognosis in colorectal carcinoma. Sci Rep. 2021;11:17863.10.1038/s41598-021-97480-4Search in Google Scholar PubMed PubMed Central

[25] du Bois H, Heim TA, Lund AW. Tumor-draining lymph nodes: At the crossroads of metastasis and immunity. Sci Immunol. 2021;6:eabg3551.10.1126/sciimmunol.abg3551Search in Google Scholar PubMed PubMed Central

[26] Mao J, Zhang Q, Zhang H, Zheng K, Wang R, Wang G. Risk factors for lymph node metastasis in papillary thyroid carcinoma: A systematic review and meta-analysis. Front Endocrinol (Lausanne). 2020;11:265.10.3389/fendo.2020.00265Search in Google Scholar PubMed PubMed Central

[27] Tsuchihashi K, Miyoshi N, Fujino S, Kitakaze M, Ohue M, Danno K, et al. Risk factors for predicting lymph node metastasis in submucosal colorectal cancer. J Anus Rectum Colon. 2022;6:181–9.10.23922/jarc.2022-002Search in Google Scholar PubMed PubMed Central

Received: 2023-08-21
Revised: 2023-10-10
Accepted: 2023-10-30
Published Online: 2023-12-13

© 2023 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Biomedical Sciences
  2. Systemic investigation of inetetamab in combination with small molecules to treat HER2-overexpressing breast and gastric cancers
  3. Immunosuppressive treatment for idiopathic membranous nephropathy: An updated network meta-analysis
  4. Identifying two pathogenic variants in a patient with pigmented paravenous retinochoroidal atrophy
  5. Effects of phytoestrogens combined with cold stress on sperm parameters and testicular proteomics in rats
  6. A case of pulmonary embolism with bad warfarin anticoagulant effects caused by E. coli infection
  7. Neutrophilia with subclinical Cushing’s disease: A case report and literature review
  8. Isoimperatorin alleviates lipopolysaccharide-induced periodontitis by downregulating ERK1/2 and NF-κB pathways
  9. Immunoregulation of synovial macrophages for the treatment of osteoarthritis
  10. Novel CPLANE1 c.8948dupT (p.P2984Tfs*7) variant in a child patient with Joubert syndrome
  11. Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms
  12. Immunological responses of septic rats to combination therapy with thymosin α1 and vitamin C
  13. High glucose and high lipid induced mitochondrial dysfunction in JEG-3 cells through oxidative stress
  14. Pharmacological inhibition of the ubiquitin-specific protease 8 effectively suppresses glioblastoma cell growth
  15. Levocarnitine regulates the growth of angiotensin II-induced myocardial fibrosis cells via TIMP-1
  16. Age-related changes in peripheral T-cell subpopulations in elderly individuals: An observational study
  17. Single-cell transcription analysis reveals the tumor origin and heterogeneity of human bilateral renal clear cell carcinoma
  18. Identification of iron metabolism-related genes as diagnostic signatures in sepsis by blood transcriptomic analysis
  19. Long noncoding RNA ACART knockdown decreases 3T3-L1 preadipocyte proliferation and differentiation
  20. Surgery, adjuvant immunotherapy plus chemotherapy and radiotherapy for primary malignant melanoma of the parotid gland (PGMM): A case report
  21. Dosimetry comparison with helical tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy for grade II gliomas: A single‑institution case series
  22. Soy isoflavone reduces LPS-induced acute lung injury via increasing aquaporin 1 and aquaporin 5 in rats
  23. Refractory hypokalemia with sexual dysplasia and infertility caused by 17α-hydroxylase deficiency and triple X syndrome: A case report
  24. Meta-analysis of cancer risk among end stage renal disease undergoing maintenance dialysis
  25. 6-Phosphogluconate dehydrogenase inhibition arrests growth and induces apoptosis in gastric cancer via AMPK activation and oxidative stress
  26. Experimental study on the optimization of ANM33 release in foam cells
  27. Primary retroperitoneal angiosarcoma: A case report
  28. Metabolomic analysis-identified 2-hydroxybutyric acid might be a key metabolite of severe preeclampsia
  29. Malignant pleural effusion diagnosis and therapy
  30. Effect of spaceflight on the phenotype and proteome of Escherichia coli
  31. Comparison of immunotherapy combined with stereotactic radiotherapy and targeted therapy for patients with brain metastases: A systemic review and meta-analysis
  32. Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation
  33. Association between the VEGFR-2 -604T/C polymorphism (rs2071559) and type 2 diabetic retinopathy
  34. The role of IL-31 and IL-34 in the diagnosis and treatment of chronic periodontitis
  35. Triple-negative mouse breast cancer initiating cells show high expression of beta1 integrin and increased malignant features
  36. mNGS facilitates the accurate diagnosis and antibiotic treatment of suspicious critical CNS infection in real practice: A retrospective study
  37. The apatinib and pemetrexed combination has antitumor and antiangiogenic effects against NSCLC
  38. Radiotherapy for primary thyroid adenoid cystic carcinoma
  39. Design and functional preliminary investigation of recombinant antigen EgG1Y162–EgG1Y162 against Echinococcus granulosus
  40. Effects of losartan in patients with NAFLD: A meta-analysis of randomized controlled trial
  41. Bibliometric analysis of METTL3: Current perspectives, highlights, and trending topics
  42. Performance comparison of three scaling algorithms in NMR-based metabolomics analysis
  43. PI3K/AKT/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic cancer
  44. The altered expression of cytoskeletal and synaptic remodeling proteins during epilepsy
  45. Effects of pegylated recombinant human granulocyte colony-stimulating factor on lymphocytes and white blood cells of patients with malignant tumor
  46. Prostatitis as initial manifestation of Chlamydia psittaci pneumonia diagnosed by metagenome next-generation sequencing: A case report
  47. NUDT21 relieves sevoflurane-induced neurological damage in rats by down-regulating LIMK2
  48. Association of interleukin-10 rs1800896, rs1800872, and interleukin-6 rs1800795 polymorphisms with squamous cell carcinoma risk: A meta-analysis
  49. Exosomal HBV-DNA for diagnosis and treatment monitoring of chronic hepatitis B
  50. Shear stress leads to the dysfunction of endothelial cells through the Cav-1-mediated KLF2/eNOS/ERK signaling pathway under physiological conditions
  51. Interaction between the PI3K/AKT pathway and mitochondrial autophagy in macrophages and the leukocyte count in rats with LPS-induced pulmonary infection
  52. Meta-analysis of the rs231775 locus polymorphism in the CTLA-4 gene and the susceptibility to Graves’ disease in children
  53. Cloning, subcellular localization and expression of phosphate transporter gene HvPT6 of hulless barley
  54. Coptisine mitigates diabetic nephropathy via repressing the NRLP3 inflammasome
  55. Significant elevated CXCL14 and decreased IL-39 levels in patients with tuberculosis
  56. Whole-exome sequencing applications in prenatal diagnosis of fetal bowel dilatation
  57. Gemella morbillorum infective endocarditis: A case report and literature review
  58. An unusual ectopic thymoma clonal evolution analysis: A case report
  59. Severe cumulative skin toxicity during toripalimab combined with vemurafenib following toripalimab alone
  60. Detection of V. vulnificus septic shock with ARDS using mNGS
  61. Novel rare genetic variants of familial and sporadic pulmonary atresia identified by whole-exome sequencing
  62. The influence and mechanistic action of sperm DNA fragmentation index on the outcomes of assisted reproduction technology
  63. Novel compound heterozygous mutations in TELO2 in an infant with You-Hoover-Fong syndrome: A case report and literature review
  64. ctDNA as a prognostic biomarker in resectable CLM: Systematic review and meta-analysis
  65. Diagnosis of primary amoebic meningoencephalitis by metagenomic next-generation sequencing: A case report
  66. Phylogenetic analysis of promoter regions of human Dolichol kinase (DOLK) and orthologous genes using bioinformatics tools
  67. Collagen changes in rabbit conjunctiva after conjunctival crosslinking
  68. Effects of NM23 transfection of human gastric carcinoma cells in mice
  69. Oral nifedipine and phytosterol, intravenous nicardipine, and oral nifedipine only: Three-arm, retrospective, cohort study for management of severe preeclampsia
  70. Case report of hepatic retiform hemangioendothelioma: A rare tumor treated with ultrasound-guided microwave ablation
  71. Curcumin induces apoptosis in human hepatocellular carcinoma cells by decreasing the expression of STAT3/VEGF/HIF-1α signaling
  72. Rare presentation of double-clonal Waldenström macroglobulinemia with pulmonary embolism: A case report
  73. Giant duplication of the transverse colon in an adult: A case report and literature review
  74. Ectopic thyroid tissue in the breast: A case report
  75. SDR16C5 promotes proliferation and migration and inhibits apoptosis in pancreatic cancer
  76. Vaginal metastasis from breast cancer: A case report
  77. Screening of the best time window for MSC transplantation to treat acute myocardial infarction with SDF-1α antibody-loaded targeted ultrasonic microbubbles: An in vivo study in miniswine
  78. Inhibition of TAZ impairs the migration ability of melanoma cells
  79. Molecular complexity analysis of the diagnosis of Gitelman syndrome in China
  80. Effects of maternal calcium and protein intake on the development and bone metabolism of offspring mice
  81. Identification of winter wheat pests and diseases based on improved convolutional neural network
  82. Ultra-multiplex PCR technique to guide treatment of Aspergillus-infected aortic valve prostheses
  83. Virtual high-throughput screening: Potential inhibitors targeting aminopeptidase N (CD13) and PIKfyve for SARS-CoV-2
  84. Immune checkpoint inhibitors in cancer patients with COVID-19
  85. Utility of methylene blue mixed with autologous blood in preoperative localization of pulmonary nodules and masses
  86. Integrated analysis of the microbiome and transcriptome in stomach adenocarcinoma
  87. Berberine suppressed sarcopenia insulin resistance through SIRT1-mediated mitophagy
  88. DUSP2 inhibits the progression of lupus nephritis in mice by regulating the STAT3 pathway
  89. Lung abscess by Fusobacterium nucleatum and Streptococcus spp. co-infection by mNGS: A case series
  90. Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis
  91. Granulomatous polyangiitis involving the fourth ventricle: Report of a rare case and a literature review
  92. Studying infant mortality: A demographic analysis based on data mining models
  93. Metaplastic breast carcinoma with osseous differentiation: A report of a rare case and literature review
  94. Protein Z modulates the metastasis of lung adenocarcinoma cells
  95. Inhibition of pyroptosis and apoptosis by capsaicin protects against LPS-induced acute kidney injury through TRPV1/UCP2 axis in vitro
  96. TAK-242, a toll-like receptor 4 antagonist, against brain injury by alleviates autophagy and inflammation in rats
  97. Primary mediastinum Ewing’s sarcoma with pleural effusion: A case report and literature review
  98. Association of ADRB2 gene polymorphisms and intestinal microbiota in Chinese Han adolescents
  99. Tanshinone IIA alleviates chondrocyte apoptosis and extracellular matrix degeneration by inhibiting ferroptosis
  100. Study on the cytokines related to SARS-Cov-2 in testicular cells and the interaction network between cells based on scRNA-seq data
  101. Effect of periostin on bone metabolic and autophagy factors during tooth eruption in mice
  102. HP1 induces ferroptosis of renal tubular epithelial cells through NRF2 pathway in diabetic nephropathy
  103. Intravaginal estrogen management in postmenopausal patients with vaginal squamous intraepithelial lesions along with CO2 laser ablation: A retrospective study
  104. Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients
  105. Effects of physical exercise on biomarkers of oxidative stress in healthy subjects: A meta-analysis of randomized controlled trials
  106. Identification of lysosome-related genes in connection with prognosis and immune cell infiltration for drug candidates in head and neck cancer
  107. Development of an instrument-free and low-cost ELISA dot-blot test to detect antibodies against SARS-CoV-2
  108. Research progress on gas signal molecular therapy for Parkinson’s disease
  109. Adiponectin inhibits TGF-β1-induced skin fibroblast proliferation and phenotype transformation via the p38 MAPK signaling pathway
  110. The G protein-coupled receptor-related gene signatures for predicting prognosis and immunotherapy response in bladder urothelial carcinoma
  111. α-Fetoprotein contributes to the malignant biological properties of AFP-producing gastric cancer
  112. CXCL12/CXCR4/CXCR7 axis in placenta tissues of patients with placenta previa
  113. Association between thyroid stimulating hormone levels and papillary thyroid cancer risk: A meta-analysis
  114. Significance of sTREM-1 and sST2 combined diagnosis for sepsis detection and prognosis prediction
  115. Diagnostic value of serum neuroactive substances in the acute exacerbation of chronic obstructive pulmonary disease complicated with depression
  116. Research progress of AMP-activated protein kinase and cardiac aging
  117. TRIM29 knockdown prevented the colon cancer progression through decreasing the ubiquitination levels of KRT5
  118. Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic target
  119. Metastasis from small cell lung cancer to ovary: A case report
  120. The early diagnosis and pathogenic mechanisms of sepsis-related acute kidney injury
  121. The effect of NK cell therapy on sepsis secondary to lung cancer: A case report
  122. Erianin alleviates collagen-induced arthritis in mice by inhibiting Th17 cell differentiation
  123. Loss of ACOX1 in clear cell renal cell carcinoma and its correlation with clinical features
  124. Signalling pathways in the osteogenic differentiation of periodontal ligament stem cells
  125. Crosstalk between lactic acid and immune regulation and its value in the diagnosis and treatment of liver failure
  126. Clinicopathological features and differential diagnosis of gastric pleomorphic giant cell carcinoma
  127. Traumatic brain injury and rTMS-ERPs: Case report and literature review
  128. Extracellular fibrin promotes non-small cell lung cancer progression through integrin β1/PTEN/AKT signaling
  129. Knockdown of DLK4 inhibits non-small cell lung cancer tumor growth by downregulating CKS2
  130. The co-expression pattern of VEGFR-2 with indicators related to proliferation, apoptosis, and differentiation of anagen hair follicles
  131. Inflammation-related signaling pathways in tendinopathy
  132. CD4+ T cell count in HIV/TB co-infection and co-occurrence with HL: Case report and literature review
  133. Clinical analysis of severe Chlamydia psittaci pneumonia: Case series study
  134. Bioinformatics analysis to identify potential biomarkers for the pulmonary artery hypertension associated with the basement membrane
  135. Influence of MTHFR polymorphism, alone or in combination with smoking and alcohol consumption, on cancer susceptibility
  136. Catharanthus roseus (L.) G. Don counteracts the ampicillin resistance in multiple antibiotic-resistant Staphylococcus aureus by downregulation of PBP2a synthesis
  137. Combination of a bronchogenic cyst in the thoracic spinal canal with chronic myelocytic leukemia
  138. Bacterial lipoprotein plays an important role in the macrophage autophagy and apoptosis induced by Salmonella typhimurium and Staphylococcus aureus
  139. TCL1A+ B cells predict prognosis in triple-negative breast cancer through integrative analysis of single-cell and bulk transcriptomic data
  140. Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
  141. Ferroptosis: A potential target of macrophages in plaque vulnerability
  142. Predicting pediatric Crohn's disease based on six mRNA-constructed risk signature using comprehensive bioinformatic approaches
  143. Applications of genetic code expansion and photosensitive UAAs in studying membrane proteins
  144. HK2 contributes to the proliferation, migration, and invasion of diffuse large B-cell lymphoma cells by enhancing the ERK1/2 signaling pathway
  145. IL-17 in osteoarthritis: A narrative review
  146. Circadian cycle and neuroinflammation
  147. Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis
  148. Hemorrhagic meningioma with pulmonary metastasis: Case report and literature review
  149. SPOP regulates the expression profiles and alternative splicing events in human hepatocytes
  150. Knockdown of SETD5 inhibited glycolysis and tumor growth in gastric cancer cells by down-regulating Akt signaling pathway
  151. PTX3 promotes IVIG resistance-induced endothelial injury in Kawasaki disease by regulating the NF-κB pathway
  152. Pancreatic ectopic thyroid tissue: A case report and analysis of literature
  153. The prognostic impact of body mass index on female breast cancer patients in underdeveloped regions of northern China differs by menopause status and tumor molecular subtype
  154. Report on a case of liver-originating malignant melanoma of unknown primary
  155. Case report: Herbal treatment of neutropenic enterocolitis after chemotherapy for breast cancer
  156. The fibroblast growth factor–Klotho axis at molecular level
  157. Characterization of amiodarone action on currents in hERG-T618 gain-of-function mutations
  158. A case report of diagnosis and dynamic monitoring of Listeria monocytogenes meningitis with NGS
  159. Effect of autologous platelet-rich plasma on new bone formation and viability of a Marburg bone graft
  160. Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
  161. Continuous non-adherent culture promotes transdifferentiation of human adipose-derived stem cells into retinal lineage
  162. Nrf3 alleviates oxidative stress and promotes the survival of colon cancer cells by activating AKT/BCL-2 signal pathway
  163. Favorable response to surufatinib in a patient with necrolytic migratory erythema: A case report
  164. Case report of atypical undernutrition of hypoproteinemia type
  165. Down-regulation of COL1A1 inhibits tumor-associated fibroblast activation and mediates matrix remodeling in the tumor microenvironment of breast cancer
  166. Sarcoma protein kinase inhibition alleviates liver fibrosis by promoting hepatic stellate cells ferroptosis
  167. Research progress of serum eosinophil in chronic obstructive pulmonary disease and asthma
  168. Clinicopathological characteristics of co-existing or mixed colorectal cancer and neuroendocrine tumor: Report of five cases
  169. Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis
  170. Precisional detection of lymph node metastasis using tFCM in colorectal cancer
  171. Advances in diagnosis and treatment of perimenopausal syndrome
  172. A study of forensic genetics: ITO index distribution and kinship judgment between two individuals
  173. Acute lupus pneumonitis resembling miliary tuberculosis: A case-based review
  174. Plasma levels of CD36 and glutathione as biomarkers for ruptured intracranial aneurysm
  175. Fractalkine modulates pulmonary angiogenesis and tube formation by modulating CX3CR1 and growth factors in PVECs
  176. Novel risk prediction models for deep vein thrombosis after thoracotomy and thoracoscopic lung cancer resections, involving coagulation and immune function
  177. Exploring the diagnostic markers of essential tremor: A study based on machine learning algorithms
  178. Evaluation of effects of small-incision approach treatment on proximal tibia fracture by deep learning algorithm-based magnetic resonance imaging
  179. An online diagnosis method for cancer lesions based on intelligent imaging analysis
  180. Medical imaging in rheumatoid arthritis: A review on deep learning approach
  181. Predictive analytics in smart healthcare for child mortality prediction using a machine learning approach
  182. Utility of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio in predicting acute-on-chronic liver failure survival
  183. A biomedical decision support system for meta-analysis of bilateral upper-limb training in stroke patients with hemiplegia
  184. TNF-α and IL-8 levels are positively correlated with hypobaric hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats
  185. Stochastic gradient descent optimisation for convolutional neural network for medical image segmentation
  186. Comparison of the prognostic value of four different critical illness scores in patients with sepsis-induced coagulopathy
  187. Application and teaching of computer molecular simulation embedded technology and artificial intelligence in drug research and development
  188. Hepatobiliary surgery based on intelligent image segmentation technology
  189. Value of brain injury-related indicators based on neural network in the diagnosis of neonatal hypoxic-ischemic encephalopathy
  190. Analysis of early diagnosis methods for asymmetric dementia in brain MR images based on genetic medical technology
  191. Early diagnosis for the onset of peri-implantitis based on artificial neural network
  192. Clinical significance of the detection of serum IgG4 and IgG4/IgG ratio in patients with thyroid-associated ophthalmopathy
  193. Forecast of pain degree of lumbar disc herniation based on back propagation neural network
  194. SPA-UNet: A liver tumor segmentation network based on fused multi-scale features
  195. Systematic evaluation of clinical efficacy of CYP1B1 gene polymorphism in EGFR mutant non-small cell lung cancer observed by medical image
  196. Rehabilitation effect of intelligent rehabilitation training system on hemiplegic limb spasms after stroke
  197. A novel approach for minimising anti-aliasing effects in EEG data acquisition
  198. ErbB4 promotes M2 activation of macrophages in idiopathic pulmonary fibrosis
  199. Clinical role of CYP1B1 gene polymorphism in prediction of postoperative chemotherapy efficacy in NSCLC based on individualized health model
  200. Lung nodule segmentation via semi-residual multi-resolution neural networks
  201. Evaluation of brain nerve function in ICU patients with Delirium by deep learning algorithm-based resting state MRI
  202. A data mining technique for detecting malignant mesothelioma cancer using multiple regression analysis
  203. Markov model combined with MR diffusion tensor imaging for predicting the onset of Alzheimer’s disease
  204. Effectiveness of the treatment of depression associated with cancer and neuroimaging changes in depression-related brain regions in patients treated with the mediator-deuterium acupuncture method
  205. Molecular mechanism of colorectal cancer and screening of molecular markers based on bioinformatics analysis
  206. Monitoring and evaluation of anesthesia depth status data based on neuroscience
  207. Exploring the conformational dynamics and thermodynamics of EGFR S768I and G719X + S768I mutations in non-small cell lung cancer: An in silico approaches
  208. Optimised feature selection-driven convolutional neural network using gray level co-occurrence matrix for detection of cervical cancer
  209. Incidence of different pressure patterns of spinal cerebellar ataxia and analysis of imaging and genetic diagnosis
  210. Pathogenic bacteria and treatment resistance in older cardiovascular disease patients with lung infection and risk prediction model
  211. Adoption value of support vector machine algorithm-based computed tomography imaging in the diagnosis of secondary pulmonary fungal infections in patients with malignant hematological disorders
  212. From slides to insights: Harnessing deep learning for prognostic survival prediction in human colorectal cancer histology
  213. Ecology and Environmental Science
  214. Monitoring of hourly carbon dioxide concentration under different land use types in arid ecosystem
  215. Comparing the differences of prokaryotic microbial community between pit walls and bottom from Chinese liquor revealed by 16S rRNA gene sequencing
  216. Effects of cadmium stress on fruits germination and growth of two herbage species
  217. Bamboo charcoal affects soil properties and bacterial community in tea plantations
  218. Optimization of biogas potential using kinetic models, response surface methodology, and instrumental evidence for biodegradation of tannery fleshings during anaerobic digestion
  219. Understory vegetation diversity patterns of Platycladus orientalis and Pinus elliottii communities in Central and Southern China
  220. Studies on macrofungi diversity and discovery of new species of Abortiporus from Baotianman World Biosphere Reserve
  221. Food Science
  222. Effect of berrycactus fruit (Myrtillocactus geometrizans) on glutamate, glutamine, and GABA levels in the frontal cortex of rats fed with a high-fat diet
  223. Guesstimate of thymoquinone diversity in Nigella sativa L. genotypes and elite varieties collected from Indian states using HPTLC technique
  224. Analysis of bacterial community structure of Fuzhuan tea with different processing techniques
  225. Untargeted metabolomics reveals sour jujube kernel benefiting the nutritional value and flavor of Morchella esculenta
  226. Mycobiota in Slovak wine grapes: A case study from the small Carpathians wine region
  227. Elemental analysis of Fadogia ancylantha leaves used as a nutraceutical in Mashonaland West Province, Zimbabwe
  228. Microbiological transglutaminase: Biotechnological application in the food industry
  229. Influence of solvent-free extraction of fish oil from catfish (Clarias magur) heads using a Taguchi orthogonal array design: A qualitative and quantitative approach
  230. Chromatographic analysis of the chemical composition and anticancer activities of Curcuma longa extract cultivated in Palestine
  231. The potential for the use of leghemoglobin and plant ferritin as sources of iron
  232. Investigating the association between dietary patterns and glycemic control among children and adolescents with T1DM
  233. Bioengineering and Biotechnology
  234. Biocompatibility and osteointegration capability of β-TCP manufactured by stereolithography 3D printing: In vitro study
  235. Clinical characteristics and the prognosis of diabetic foot in Tibet: A single center, retrospective study
  236. Agriculture
  237. Biofertilizer and NPSB fertilizer application effects on nodulation and productivity of common bean (Phaseolus vulgaris L.) at Sodo Zuria, Southern Ethiopia
  238. On correlation between canopy vegetation and growth indexes of maize varieties with different nitrogen efficiencies
  239. Exopolysaccharides from Pseudomonas tolaasii inhibit the growth of Pleurotus ostreatus mycelia
  240. A transcriptomic evaluation of the mechanism of programmed cell death of the replaceable bud in Chinese chestnut
  241. Melatonin enhances salt tolerance in sorghum by modulating photosynthetic performance, osmoregulation, antioxidant defense, and ion homeostasis
  242. Effects of plant density on alfalfa (Medicago sativa L.) seed yield in western Heilongjiang areas
  243. Identification of rice leaf diseases and deficiency disorders using a novel DeepBatch technique
  244. Artificial intelligence and internet of things oriented sustainable precision farming: Towards modern agriculture
  245. Animal Sciences
  246. Effect of ketogenic diet on exercise tolerance and transcriptome of gastrocnemius in mice
  247. Combined analysis of mRNA–miRNA from testis tissue in Tibetan sheep with different FecB genotypes
  248. Isolation, identification, and drug resistance of a partially isolated bacterium from the gill of Siniperca chuatsi
  249. Tracking behavioral changes of confined sows from the first mating to the third parity
  250. The sequencing of the key genes and end products in the TLR4 signaling pathway from the kidney of Rana dybowskii exposed to Aeromonas hydrophila
  251. Development of a new candidate vaccine against piglet diarrhea caused by Escherichia coli
  252. Plant Sciences
  253. Crown and diameter structure of pure Pinus massoniana Lamb. forest in Hunan province, China
  254. Genetic evaluation and germplasm identification analysis on ITS2, trnL-F, and psbA-trnH of alfalfa varieties germplasm resources
  255. Tissue culture and rapid propagation technology for Gentiana rhodantha
  256. Effects of cadmium on the synthesis of active ingredients in Salvia miltiorrhiza
  257. Cloning and expression analysis of VrNAC13 gene in mung bean
  258. Chlorate-induced molecular floral transition revealed by transcriptomes
  259. Effects of warming and drought on growth and development of soybean in Hailun region
  260. Effects of different light conditions on transient expression and biomass in Nicotiana benthamiana leaves
  261. Comparative analysis of the rhizosphere microbiome and medicinally active ingredients of Atractylodes lancea from different geographical origins
  262. Distinguish Dianthus species or varieties based on chloroplast genomes
  263. Comparative transcriptomes reveal molecular mechanisms of apple blossoms of different tolerance genotypes to chilling injury
  264. Study on fresh processing key technology and quality influence of Cut Ophiopogonis Radix based on multi-index evaluation
  265. An advanced approach for fig leaf disease detection and classification: Leveraging image processing and enhanced support vector machine methodology
  266. Erratum
  267. Erratum to “Protein Z modulates the metastasis of lung adenocarcinoma cells”
  268. Erratum to “BRCA1 subcellular localization regulated by PI3K signaling pathway in triple-negative breast cancer MDA-MB-231 cells and hormone-sensitive T47D cells”
  269. Retraction
  270. Retraction to “Protocatechuic acid attenuates cerebral aneurysm formation and progression by inhibiting TNF-alpha/Nrf-2/NF-kB-mediated inflammatory mechanisms in experimental rats”
Downloaded on 7.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2022-0780/html
Scroll to top button